GENEVA, July 9 -- ARNATAR THERAPEUTICS, INC filed a patent application (US2025/061699) for “ADVANCED RNA TARGETING (ARNATAR) FOR CFB”. With publication no. WO/2026/148037, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/713
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....